Halaman 3 - Transplantasi sumsum tulang Dokter Terbaik - TOP-88 dokter

Dr. Mahmoud M. El Zembely is a pediatric oncologist and malignant hematologist. He manages acute lymphoblastic leukemia, acute myeloid leukemia, and chronic myeloid leukemia. He treats Hodgkin and non‑Hodgkin lymphomas, nephroblastoma, neuroblastoma, and bone and liver tumors. His work includes gonadal and extragonadal germ cell tumors, rhabdomyosarcoma, and non‑rhabdomyosarcoma soft tissue sarcomas. He also cares for rare cancers and survivorship.

Accreditations: M.B.B.Ch, Assiut University, 2006. Master’s in Pediatric Oncology and Malignant Hematology, 2011. Clinical fellowship in pediatric bone marrow transplantation, Seattle Cancer Care Alliance, 2015–2017. Doctorate, 2020.

Roles: South Egypt Cancer Institute–Assiut University: Pediatric Oncology, 2008–2012. Assistant Lecturer, 2012–2019. Lecturer, 2020–2024. Shefa Al‑Orman Cancer Center, Luxor: Head of Pediatric Oncology, 2020–present.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Iris Kventsel, MD, is a pediatric hemato-oncologist and bone marrow transplant (BMT) specialist at Sheba Medical Center. She is an attending physician in the Pediatric Hemato-Oncology and BMT Division at the Edmond and Lily Safra Children’s Hospital. Her clinical focus is pediatric sarcomas, including Ewing sarcoma, osteosarcoma, and rhabdomyosarcoma.

She provides multidisciplinary care, including transplant and cellular therapies. She also uses current chemotherapy protocols and targeted therapies for complex childhood cancers.

Her research focuses on genetic cancer predisposition, including Li-Fraumeni syndrome, and cancer susceptibility genes. She has published in pediatric oncology, stem cell biology, and surgical oncology (HIPEC). She is on the academic staff at Tel Aviv University. Education: MD, Technion; Pediatrics residency, Assaf HaRofeh; Pediatric Hemato-Oncology fellowship, Sheba.

Prof. Elad Jacoby, MD, heads the Pediatric Cell Therapy Center at Sheba Medical Center. He is the Medical Director of the Advanced Biotherapy Center. He is a pioneer of pediatric CAR T‑cell therapy in Israel. He led one of the first national leukemia programs. He has almost 20 years of clinical and research experience.

He specializes in CAR T‑cell therapy, bone marrow and stem cell transplantation, and high‑risk pediatric leukemias and lymphomas. He leads international clinical trials and has authored over 240 publications. His collaborations include Johns Hopkins Hospital and the U.S. National Cancer Institute. He is an Associate Professor at Tel Aviv University. He received his MD from Tel Aviv University, completed residency at Sheba Medical Center, and fellowships at Johns Hopkins and the National Cancer Institute. He is board‑certified in Pediatrics and in Pediatric Hematology and Oncology. He serves on the IBFM CAR T‑Cell Taskforce and the Sheba Institutional Review Board. He leads the integration of CAR T‑cell therapy with transplantation.

Dr. Abraham Avigdor, MD, is Director of the Institute of Hematology and Co‑Director of the Hematology & Bone Marrow Transplantation Division at Sheba Medical Center. He is an international leader in lymphoma, CAR‑T, and advanced hemato‑oncology with more than 35 years of experience. His clinical focus includes lymphomas, multiple myeloma, and complex blood cancers.

He is a pioneer in CAR‑T integration. He leads cellular therapy and bone marrow transplantation programs (autologous and allogeneic). He also advances stem cell therapies and precision diagnostics, including PET/CT‑based prognostics. His work includes immunotherapy and targeted regimens and the development of innovative, data‑driven protocols.

He collaborates with LYSA, EMCL, and international PET groups. He has authored more than 130 publications. Key roles include Founder and President of the Israeli Lymphoma Working Group, former Chair of the Israeli Lymphoma Study Group, and Senior Lecturer at Tel Aviv University. Education: MD, Ben‑Gurion University; residency, Sheba Medical Center; postdoctoral fellowship, Weizmann Institute. Awards include the Knesset Prize, the Israeli Ministry of Health Award, and the Sackler Prize.

Profesor Zila Zuckerman berspesialisasi dalam hematologi dan transplantasi sumsum tulang di Rambam Medical Center.

• Keahlian dalam hematologi dan transplantologi
• Kualifikasi tingkat Profesor di bidang tersebut
• Berpraktik di pusat medis terkemuka

Profesor Dina Ben-Yehuda mengepalai Departemen Hematologi di Pusat Medis Hadassah, merintis transplantasi sumsum tulang dan terapi gen.

• Berspesialisasi dalam diagnostik molekuler untuk penyakit darah ganas
• Dihormati dengan Penghargaan Kepala Staf untuk layanan luar biasa
• Dekan wanita pertama di Fakultas Kedokteran Hadassah
• Pelatihan di Memorial Sloan-Kettering Cancer Center di New York
• Penerima Penghargaan "Healing with the Heart Award" untuk perawatan pasien

Telah melakukan lebih dari 3.500 transplantasi sumsum tulang – Dr. Stepensky berfokus pada penyelamatan nyawa anak-anak di Pusat Medis Hadassah.

• 20 tahun pengalaman dalam transplantasi sumsum tulang pediatrik
• Diakui oleh Forbes sebagai salah satu dokter terbaik pada tahun 2018
• Mengkhususkan diri pada penyakit kanker darah langka pada anak-anak
• Dikenal di kalangan pasien sebagai orang yang 'mentransplantasikan kehidupan'

Dr. Irina Zaidman berspesialisasi dalam transplantasi sumsum tulang pediatrik di Hadassah Medical Center, dengan pelatihan lanjutan dari institusi terkemuka di seluruh dunia.

• Fellowship dalam TST pediatrik di Hospital for Sick Children di Toronto
• Anggota dewan Masyarakat Hemato-Onkologi Pediatrik Israel
• Telah menerbitkan beberapa artikel tentang transplantasi sumsum tulang pediatrik
• Anggota masyarakat TST Eropa dan Amerika

Dr. Spielberg berspesialisasi dalam transplantasi sumsum tulang di Assuta Medical Center, fasilitas terkemuka untuk perawatan hematologi.

• Onkohematolog dengan fokus pada transplantasi sumsum tulang
• Bekerja di Assuta Medical Center, yang dikenal dengan perawatan hematologi tingkat lanjut
• Berdedikasi untuk menangani kondisi hematologi yang kompleks

Dr. Hila Magen, MD, leads the Multiple Myeloma and Amyloidosis Unit at Sheba Medical Center. She is a hemato-oncologist with over 35 years of experience. She is a leading Israeli expert in multiple myeloma and plasma cell disorders.

She runs a program that provides personalized care and early access to clinical trials. This includes CAR-T therapy for high-risk and relapsed or refractory myeloma and amyloidosis. Dr. Magen is a principal investigator in point-of-care CAR-T studies. She brings new immunotherapies into routine care.

Training: Fellowships in Multiple Myeloma (UAMS) and Lymphocytic Leukemia (MD Anderson). Academic: Instructor, Tel Aviv University. Research: Author of 100+ publications, contributor to landmark myeloma studies, and reviewer for international journals.

Prof. Avichai Shimoni, MD, is Director of Bone Marrow Transplantation at Sheba Medical Center. He is a hemato-oncologist with over 30 years of experience in bone marrow transplantation, cellular therapies, and advanced blood cancer care.

He leads a high-volume program for complex, high-risk blood cancers. He performs allogeneic and autologous transplants. He also provides CAR T-cell therapy for leukemia, lymphoma, and multiple myeloma. He completed a bone marrow transplantation fellowship at MD Anderson Cancer Center.

He is Chairman of Hematology at Tel Aviv University and a Professor of Hematology. He has authored more than 250 scientific papers. His research focuses on CAR T-cell therapy and stem cell transplantation. He is often listed among Israel's Best Doctors (Forbes 2025 and 2026).

Kepala program transplantasi sumsum tulang terbesar di Italia, yang melakukan lebih dari 90 transplantasi alogenik setiap tahun di San Raffaele. Beliau adalah salah satu spesialis limfoma terkemuka di negara tersebut.

• Memimpin Unit Transplantasi Sumsum Tulang sejak 2006
• Spesialisasi dalam hematologi dan penyakit dalam dari Universitas Milan
• Telah memublikasikan 70+ studi tentang transplantasi dan kanker darah
• Anggota European Society for Blood and Marrow Transplantation

Direktur Unit Limfoma di San Raffaele – Prof. Ferreri mendirikan Yayasan Limfoma Italia untuk studi klinis lanjutan.

• Wakil Direktur Hematologi Onkologi dengan pengalaman 20+ tahun
• Penulis 300+ makalah tentang pengobatan limfoma
• Berspesialisasi dalam penelitian limfoma non-Hodgkin
• Anggota European Hematology Association & American Society of Hematology

Prof. Dr. Serdar Bedii Omay telah menerbitkan lebih dari 65 artikel ilmiah mengenai hematologi dan transplantasi sumsum tulang, dengan pengalaman luas di bidang tersebut.

• Mendapat pelatihan di bidang hematologi molekuler di Fakultas Kedokteran Mie, Jepang
• Profesor Hematologi di Universitas Teknik Ege dan Karadeniz
• Berspesialisasi dalam penyakit dalam dan hematologi sejak tahun 1990
• Penulis 112 makalah pertemuan dan 34 presentasi konferensi